Vycor Medical, Inc. (OTCMKTS:VYCO) Sees Large Decrease in Short Interest

Vycor Medical, Inc. (OTCMKTS:VYCO) was the recipient of a significant decline in short interest in May. As of May 29th, there was short interest totaling 7,489 shares, a decline of 34.2% from the May 14th total of 11,389 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 13,377 shares, the short-interest ratio is currently 0.6 days.

Vycor Medical Price Performance

VYCO stock opened at $0.07 on Tuesday. Vycor Medical has a 52 week low of $0.03 and a 52 week high of $0.20. The company’s 50-day moving average price is $0.07 and its 200 day moving average price is $0.11.

About Vycor Medical

Vycor Medical, Inc is a medical device company specializing in the design, development and manufacture of minimally invasive cranial access systems for use in neurosurgery. The company’s proprietary endoport platform is engineered to provide neurosurgeons with controlled, cannula-based access for intracranial procedures such as tumor biopsy, resection and hematoma drainage. By integrating visualization channels and atraumatic retraction technology, Vycor’s products are intended to reduce collateral damage to healthy brain tissue and streamline procedural workflows.

The company’s core portfolio includes its flagship endoport system along with complementary accessories such as obturators, sheaths and closure devices.